Your browser doesn't support javascript.
loading
Optimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patients.
Mato, A R; Hill, B T; Lamanna, N; Barr, P M; Ujjani, C S; Brander, D M; Howlett, C; Skarbnik, A P; Cheson, B D; Zent, C S; Pu, J J; Kiselev, P; Foon, K; Lenhart, J; Henick Bachow, S; Winter, A M; Cruz, A-L; Claxton, D F; Goy, A; Daniel, C; Isaac, K; Kennard, K H; Timlin, C; Fanning, M; Gashonia, L; Yacur, M; Svoboda, J; Schuster, S J; Nabhan, C.
Afiliación
  • Mato AR; Center for CLL, Abramson Cancer Center, University of Pennsylvania, Philadelphia, USA.
  • Hill BT; Taussig Cancer Institute, Cleveland Clinic, Cleveland, USA.
  • Lamanna N; Division of Hematology and Oncology, New York Presbyterian/Columbia University Medical Center, New York, USA.
  • Barr PM; Wilmot Cancer Institute, University of Rochester, Rochester, USA.
  • Ujjani CS; Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, USA.
  • Brander DM; Duke University Medical Center, Durham, USA.
  • Howlett C; Department of Pharmacy and Clinical Services, John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, USA.
  • Skarbnik AP; Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, USA.
  • Cheson BD; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, USA.
  • Zent CS; Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, USA.
  • Pu JJ; Wilmot Cancer Institute, University of Rochester, Rochester, USA.
  • Kiselev P; Penn State Hershey Cancer Institute, Penn State University College of Medicine, Hershey, USA.
  • Foon K; Celgene Corporation, Summit, USA.
  • Lenhart J; Celgene Corporation, Summit, USA.
  • Henick Bachow S; Celgene Corporation, Summit, USA.
  • Winter AM; Division of Hematology and Oncology, New York Presbyterian/Columbia University Medical Center, New York, USA.
  • Cruz AL; Taussig Cancer Institute, Cleveland Clinic, Cleveland, USA.
  • Claxton DF; Medstar Washington Hospital Center, Washington, USA.
  • Goy A; Penn State Hershey Cancer Institute, Penn State University College of Medicine, Hershey, USA.
  • Daniel C; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, USA.
  • Isaac K; Center for CLL, Abramson Cancer Center, University of Pennsylvania, Philadelphia, USA.
  • Kennard KH; Center for CLL, Abramson Cancer Center, University of Pennsylvania, Philadelphia, USA.
  • Timlin C; Center for CLL, Abramson Cancer Center, University of Pennsylvania, Philadelphia, USA.
  • Fanning M; Center for CLL, Abramson Cancer Center, University of Pennsylvania, Philadelphia, USA.
  • Gashonia L; Center for CLL, Abramson Cancer Center, University of Pennsylvania, Philadelphia, USA.
  • Yacur M; Center for CLL, Abramson Cancer Center, University of Pennsylvania, Philadelphia, USA.
  • Svoboda J; Penn State Hershey Cancer Institute, Penn State University College of Medicine, Hershey, USA.
  • Schuster SJ; Center for CLL, Abramson Cancer Center, University of Pennsylvania, Philadelphia, USA.
  • Nabhan C; Center for CLL, Abramson Cancer Center, University of Pennsylvania, Philadelphia, USA.
Ann Oncol ; 28(5): 1050-1056, 2017 05 01.
Article en En | MEDLINE | ID: mdl-28453705
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Año: 2017 Tipo del documento: Article